GlassScriptPhysician profile
Andrew C Harbin
NPI 1386878874
$10,606.43
in general payments reported to CMS, 2019-2025
39 companies · $3,801 in 2025
The $3,801 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,314 · 2020: $245 · 2021: $1,109 · 2022: $600 · 2023: $1,676 · 2024: $1,861 · 2025: $3,801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $2,353 · Food and Beverage: $2,351 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $2,352.56 |
| Food and Beverage | $2,351.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,142.36 | 2019-2025 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $521.82 | 2019-2024 | Aquabeam System |
| Astellas Pharma US INC | $442.68 | 2019-2024 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $341.99 | 2019-2024 | Erleada, Akeega |
| Urogen Pharma, INC. | $206.18 | 2021-2025 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $200.07 | 2021-2023 | Prolaris |
| Olympus America INC. | $199.88 | 2022-2024 | Itind System |
| Sumitomo Pharma America, INC. | $183.14 | 2023-2025 | Orgovyx |
| Davol INC. | $175.37 | 2021-2025 | Phasix Mesh |
| Teleflex LLC | $171.43 | 2021-2022 | |
| Coloplast Corp | $164.81 | 2021-2025 | Speedicath, Porges Coloplast |
| Baxter Healthcare | $152.88 | 2019-2021 | |
| Neotract INC. | $135.50 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $132.90 | 2022-2024 | |
| Endo Pharmaceuticals INC. | $132.17 | 2019-2020 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $128.85 | 2019-2024 | Spaceoar Vue System - 10ml |
| Novartis Pharmaceuticals Corporation | $114.28 | 2022-2025 | |
| Abbvie INC. | $109.67 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $100.22 | 2025 | Erleada |
| Medtronic, INC. | $95.00 | 2023 | Interstim |
| Medtronic USA, INC. | $91.77 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.56 | 2019-2021 | |
| Antares Pharma, INC. | $64.02 | 2019-2025 | Xyosted |
| Pfizer INC. | $61.59 | 2022-2024 | |
| Myovant Sciences INC. | $59.35 | 2021 | |
| Bioprotect Medical, INC. | $50.29 | 2025 | Bioprotect Balloon Implant System |
| Janssen Scientific Affairs, LLC | $42.41 | 2023 | Erleada |
| Verity Pharmaceuticals INC. | $38.22 | 2025 | Trelstar |
| Merck Sharp & Dohme LLC | $36.07 | 2021-2023 | Lynparza, Keytruda |
| Allergan, INC. | $34.97 | 2019-2022 | |
| Amgen INC. | $32.78 | 2019-2021 | |
| Tempus Ai, INC | $22.79 | 2024 | |
| 180 Medical, INC. | $21.90 | 2024 | Gentlecath |
| Accord Healthcare, INC. | $21.26 | 2024 | |
| Calyxo, INC. | $21.13 | 2025 | Cvac Aspiration System |
| Dendreon Pharmaceuticals LLC | $20.20 | 2025 | Provenge |
| Hollister Incorporated | $19.58 | 2023 | Infyna Chic, Vapro |
| Tolmar Pharmaceuticals, INC. | $13.70 | 2019 | |
| Palette Life Sciences, INC. | $11.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Harbin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.